Cargando…

LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305

OBJECTIVE: Cisplatin resistance is one of the main reasons for treatment failure in ovarian cancer (OC). Here, the effects of LINC00184 on cisplatin-resistant OC were studied. PATIENTS AND METHODS: LINC00184, miR-1305 and CNTN1 expression in tissues from 70 OC patients was determined by qRT-PCR, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yuwen, You, Jun, Han, Yun, Liu, Yinglei, Huang, Menghui, Lu, Xiaoyan, Chen, Jingjing, Zheng, Yanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064690/
https://www.ncbi.nlm.nih.gov/pubmed/33907415
http://dx.doi.org/10.2147/OTT.S280490
_version_ 1783682189632733184
author Han, Yuwen
You, Jun
Han, Yun
Liu, Yinglei
Huang, Menghui
Lu, Xiaoyan
Chen, Jingjing
Zheng, Yanli
author_facet Han, Yuwen
You, Jun
Han, Yun
Liu, Yinglei
Huang, Menghui
Lu, Xiaoyan
Chen, Jingjing
Zheng, Yanli
author_sort Han, Yuwen
collection PubMed
description OBJECTIVE: Cisplatin resistance is one of the main reasons for treatment failure in ovarian cancer (OC). Here, the effects of LINC00184 on cisplatin-resistant OC were studied. PATIENTS AND METHODS: LINC00184, miR-1305 and CNTN1 expression in tissues from 70 OC patients was determined by qRT-PCR, in situ hybridization and Western blot. OC cell lines and OC cisplatin-resistant cell lines were cultured. Cells were transfected using Lipofectamine 2000 and treated with 100 nM cisplatin. Cell proliferation and apoptosis were researched by the CCK-8 assay and flow cytometry. A dual-luciferase reporter gene assay and RNA pull-down were performed to explore the relationship between two genes. LINC00184, miR-1305 and CNTN1 expression in cells was detected by qRT-PCR and Western blot. An in vivo experiment was conducted using nude mice. Ki67 and CNTN1 expression and apoptosis of xenograft tumors were investigated using immunohistochemistry and a TUNEL assay. RESULTS: LINC00184 was up-regulated in OC clinical tissues and OC cells, especially in cisplatin-resistant OC patients and cells (p<0.01 or p<0.0001). LINC00184 overexpression significantly enhanced OC cell proliferation and cisplatin resistance, and inhibited OC cell apoptosis (p<0.05 or p<0.01). LINC00184 elevated CNTN1 expression via sponging miR-1305. LINC00184 overexpression markedly exacerbated the malignant phenotype of OC cells and cisplatin-resistant OC cells via the miR-1305/CNTN1 axis (p<0.01). Silencing of LINC00184 significantly suppressed OC cell growth and cisplatin resistance in vivo (p<0.01). LINC00184 silencing inhibited Ki67 and CNTN1 expression and promoted apoptosis of xenograft tumors. CNTN1 overexpression promoted proliferation and cisplatin resistance, and reduced apoptosis of OC cells (p<0.05 or p<0.01). CONCLUSION: LINC00184 promoted OC cell proliferation and cisplatin resistance by elevating CNTN1 expression via sponging miR-1305.
format Online
Article
Text
id pubmed-8064690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80646902021-04-26 LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305 Han, Yuwen You, Jun Han, Yun Liu, Yinglei Huang, Menghui Lu, Xiaoyan Chen, Jingjing Zheng, Yanli Onco Targets Ther Original Research OBJECTIVE: Cisplatin resistance is one of the main reasons for treatment failure in ovarian cancer (OC). Here, the effects of LINC00184 on cisplatin-resistant OC were studied. PATIENTS AND METHODS: LINC00184, miR-1305 and CNTN1 expression in tissues from 70 OC patients was determined by qRT-PCR, in situ hybridization and Western blot. OC cell lines and OC cisplatin-resistant cell lines were cultured. Cells were transfected using Lipofectamine 2000 and treated with 100 nM cisplatin. Cell proliferation and apoptosis were researched by the CCK-8 assay and flow cytometry. A dual-luciferase reporter gene assay and RNA pull-down were performed to explore the relationship between two genes. LINC00184, miR-1305 and CNTN1 expression in cells was detected by qRT-PCR and Western blot. An in vivo experiment was conducted using nude mice. Ki67 and CNTN1 expression and apoptosis of xenograft tumors were investigated using immunohistochemistry and a TUNEL assay. RESULTS: LINC00184 was up-regulated in OC clinical tissues and OC cells, especially in cisplatin-resistant OC patients and cells (p<0.01 or p<0.0001). LINC00184 overexpression significantly enhanced OC cell proliferation and cisplatin resistance, and inhibited OC cell apoptosis (p<0.05 or p<0.01). LINC00184 elevated CNTN1 expression via sponging miR-1305. LINC00184 overexpression markedly exacerbated the malignant phenotype of OC cells and cisplatin-resistant OC cells via the miR-1305/CNTN1 axis (p<0.01). Silencing of LINC00184 significantly suppressed OC cell growth and cisplatin resistance in vivo (p<0.01). LINC00184 silencing inhibited Ki67 and CNTN1 expression and promoted apoptosis of xenograft tumors. CNTN1 overexpression promoted proliferation and cisplatin resistance, and reduced apoptosis of OC cells (p<0.05 or p<0.01). CONCLUSION: LINC00184 promoted OC cell proliferation and cisplatin resistance by elevating CNTN1 expression via sponging miR-1305. Dove 2021-04-19 /pmc/articles/PMC8064690/ /pubmed/33907415 http://dx.doi.org/10.2147/OTT.S280490 Text en © 2021 Han et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Han, Yuwen
You, Jun
Han, Yun
Liu, Yinglei
Huang, Menghui
Lu, Xiaoyan
Chen, Jingjing
Zheng, Yanli
LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
title LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
title_full LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
title_fullStr LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
title_full_unstemmed LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
title_short LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
title_sort linc00184 promotes ovarian cancer cells proliferation and cisplatin resistance by elevating cntn1 expression via sponging mir-1305
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064690/
https://www.ncbi.nlm.nih.gov/pubmed/33907415
http://dx.doi.org/10.2147/OTT.S280490
work_keys_str_mv AT hanyuwen linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT youjun linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT hanyun linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT liuyinglei linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT huangmenghui linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT luxiaoyan linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT chenjingjing linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305
AT zhengyanli linc00184promotesovariancancercellsproliferationandcisplatinresistancebyelevatingcntn1expressionviaspongingmir1305